QuidelOrtho Management
Management criteria checks 1/4
QuidelOrtho's CEO is Brian Blaser, appointed in May 2024, has a tenure of 1.33 years. total yearly compensation is $15.04M, comprised of 4.2% salary and 95.8% bonuses, including company stock and options. directly owns 0.026% of the company’s shares, worth MX$9.36M. The average tenure of the management team and the board of directors is 1.2 years and 5.1 years respectively.
Key information
Brian Blaser
Chief executive officer
US$15.0m
Total compensation
| CEO salary percentage | 4.22% |
| CEO tenure | 1.3yrs |
| CEO ownership | 0.03% |
| Management average tenure | 1.2yrs |
| Board average tenure | 5.1yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 29 2025 | n/a | n/a | -US$466m |
| Mar 30 2025 | n/a | n/a | -US$359m |
| Dec 29 2024 | US$15m | US$635k | -US$2b |
Compensation vs Market: Brian's total compensation ($USD15.04M) is above average for companies of similar size in the MX market ($USD481.25K).
Compensation vs Earnings: Insufficient data to compare Brian's compensation with company performance.
CEO
Brian Blaser (60 yo)
Mr. Brian J. Blaser serves as CEO & President at QuidelOrtho Corporation since May 06, 2024 & serves as it's Director since May 15, 2024. He served as an Independent Director at Quanterix Corporation since...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.3yrs | US$15.04m | 0.026% MX$ 9.4m | |
| Chief Financial Officer | 3.3yrs | US$4.70m | 0.049% MX$ 18.0m | |
| Chief Operations Officer | less than a year | US$1.62m | 0.020% MX$ 7.1m | |
| Executive VP of Research & Development and CTO | less than a year | US$2.72m | no data | |
| Chief Legal Officer & Corporate Secretary | 4.8yrs | US$3.31m | 0.043% MX$ 15.6m | |
| Vice President of Investor Relations | 2yrs | no data | no data | |
| Vice President of Global Marketing & Corporate Communications | no data | no data | no data | |
| Executive Vice President of Strategy & Corporate Development | less than a year | no data | no data | |
| Chief Human Resources Officer | 1.1yrs | no data | no data | |
| Point of Care Business Unit Leader | no data | no data | no data | |
| Senior Vice President of Molecular Diagnostics & Point of Care | no data | no data | no data | |
| Head of JAPAC (Japan | no data | no data | no data |
Experienced Management: QDEL1 *'s management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 1.3yrs | US$15.04m | 0.026% MX$ 9.4m | |
| Independent Director | 5.1yrs | US$318.72k | 0.021% MX$ 7.6m | |
| Independent Director | 10.8yrs | US$325.72k | 0.050% MX$ 18.2m | |
| Independent Non-Executive Chairman | 17.8yrs | US$421.96k | 0.15% MX$ 54.8m | |
| Independent Director | 6.8yrs | US$332.25k | 0.031% MX$ 11.4m | |
| Independent Director | 32.6yrs | US$306.24k | 0.043% MX$ 15.5m | |
| Independent Director | 3.3yrs | US$283.75k | 0.016% MX$ 5.7m | |
| Independent Director | less than a year | US$96.39k | 0.0037% MX$ 1.4m | |
| Independent Director | 7.4yrs | US$283.75k | 0.051% MX$ 18.4m | |
| Independent Director | less than a year | US$96.39k | 0.0037% MX$ 1.4m | |
| Independent Director | 4.6yrs | US$283.75k | 0.017% MX$ 6.2m |
Experienced Board: QDEL1 *'s board of directors are considered experienced (5.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/09/01 15:52 |
| End of Day Share Price | 2025/06/04 00:00 |
| Earnings | 2025/06/29 |
| Annual Earnings | 2024/12/29 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
QuidelOrtho Corporation is covered by 23 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Daniel Owczarski | Avondale Partners |
| Mark Massaro | Canaccord Genuity |
| Patrick Donnelly | Citigroup Inc |